Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshihiro Onishi

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Proceedings. Mathematical, Physical, and Engineering Sciences|November 11, 2014
Some new addition formulae for Weierstrass elliptic functionsJ Chris Eilbeck, Matthew England, Yoshihiro Onishi
Clinical Kidney Journal|July 5, 2024
Association between magnesium, erythropoietin resistance and mortality: the Japanese Dialysis Outcomes and Practice Patterns Study (J-DOPPS)Sawako Kato, Jui Wang, Yoshihiro Onishi, et al.
Kidney International Reports|September 14, 2023
Infectious Risk and Variability of Hemoglobin Level in Patients Undergoing HemodialysisHiroshi Nishi, Jui Wang, Yoshihiro Onishi, et al.
AJPM Focus|May 13, 2024
Development of a Culinary Intervention (Cooking Class) for Salt Reduction in Japanese Home Cooking: Strategies and AssessmentMiyuki Imamoto, Toshihiko Takada, Sho Sasaki, et al.
Scientific Reports|March 2, 2018
Multimorbidity patterns in relation to polypharmacy and dosage frequency: a nationwide, cross-sectional study in a Japanese populationTakuya Aoki, Yosuke Yamamoto, Tatsuyoshi Ikenoue, et al.
Plos One|March 9, 2017
Development of a new risk model for predicting cardiovascular events among hemodialysis patients: Population-based hemodialysis patients from the Japan Dialysis Outcome and Practice Patterns Study (J-DOPPS)Yukiko Matsubara, Miho Kimachi, Shingo Fukuma, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|August 24, 2017
RAS Inhibitor Is Not Associated With Cardiovascular Benefits in Patients Undergoing Hemodialysis in JapanMasahide Mizobuchi, Hiroaki Ogata, Yoshihiro Onishi, et al.
American Journal of Nephrology|April 22, 2011
Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5DMasafumi Fukagawa, Hirotaka Komaba, Yoshihiro Onishi, et al.
Clinical Kidney Journal|November 28, 2015
Contribution of dysregulated serum magnesium to mortality in hemodialysis patients with secondary hyperparathyroidism: a 3-year cohort studyNoriaki Kurita, Tadao Akizawa, Masafumi Fukagawa, et al.
American Journal of Nephrology|November 22, 2017
Interactive Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers or Their Combination on Survival of Hemodialysis PatientsRyo Kido, Tadao Akizawa, Masafumi Fukagawa, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Proceedings. Mathematical, Physical, and Engineering Sciences|November 11, 2014
Some new addition formulae for Weierstrass elliptic functionsJ Chris Eilbeck, Matthew England, Yoshihiro Onishi
Clinical Kidney Journal|July 5, 2024
Association between magnesium, erythropoietin resistance and mortality: the Japanese Dialysis Outcomes and Practice Patterns Study (J-DOPPS)Sawako Kato, Jui Wang, Yoshihiro Onishi, et al.
Kidney International Reports|September 14, 2023
Infectious Risk and Variability of Hemoglobin Level in Patients Undergoing HemodialysisHiroshi Nishi, Jui Wang, Yoshihiro Onishi, et al.
AJPM Focus|May 13, 2024
Development of a Culinary Intervention (Cooking Class) for Salt Reduction in Japanese Home Cooking: Strategies and AssessmentMiyuki Imamoto, Toshihiko Takada, Sho Sasaki, et al.
Scientific Reports|March 2, 2018
Multimorbidity patterns in relation to polypharmacy and dosage frequency: a nationwide, cross-sectional study in a Japanese populationTakuya Aoki, Yosuke Yamamoto, Tatsuyoshi Ikenoue, et al.
Plos One|March 9, 2017
Development of a new risk model for predicting cardiovascular events among hemodialysis patients: Population-based hemodialysis patients from the Japan Dialysis Outcome and Practice Patterns Study (J-DOPPS)Yukiko Matsubara, Miho Kimachi, Shingo Fukuma, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|August 24, 2017
RAS Inhibitor Is Not Associated With Cardiovascular Benefits in Patients Undergoing Hemodialysis in JapanMasahide Mizobuchi, Hiroaki Ogata, Yoshihiro Onishi, et al.
American Journal of Nephrology|April 22, 2011
Mineral metabolism management in hemodialysis patients with secondary hyperparathyroidism in Japan: baseline data from the MBD-5DMasafumi Fukagawa, Hirotaka Komaba, Yoshihiro Onishi, et al.
Clinical Kidney Journal|November 28, 2015
Contribution of dysregulated serum magnesium to mortality in hemodialysis patients with secondary hyperparathyroidism: a 3-year cohort studyNoriaki Kurita, Tadao Akizawa, Masafumi Fukagawa, et al.
American Journal of Nephrology|November 22, 2017
Interactive Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers or Their Combination on Survival of Hemodialysis PatientsRyo Kido, Tadao Akizawa, Masafumi Fukagawa, et al.
Pageof 7